The aging population is creating a massive tailwind for companies that provide cutting-edge health care.
Before I give my recommendation I want to visit with the charts and indicators.
Omeros Corp. and EyePoint Pharmaceuticals each have promising treatments that could send their shares skyward.
In addition to the yield let's check out the charts of ABBV.
Reata Pharmaceuticals and Axsome Therapeutics each have had a terrific 2019, which helps offset the losing bets in this high-beta sector of the market.
China trade issue is no longer dominating the action.
Checking on the charts of InMode and BioLife Solutions.
These small biotech concerns are undervalued.
The two are homebuilding and biotech, and there are stocks within those sectors where I've parked my money.
Let's check and see if the charts and indicators suggest where prices might bottom out.